 In this study , we examined the in vitro effect of tobramycin-efflux pump inhibitor ( TOB-EPI) conjugates in combinations with fluoroquinolones<disease> , rifampicin and fosfomycin on the growth of multi-drug resistant ( MDR) and extremely-drug resistant ( XDR)